» Articles » PMID: 37010333

Excisional Endometriosis Surgery with Hysterectomy and Bilateral Salpingo-oophorectomy Versus Excisional Endometriosis Surgery Alone for Pelvic Pain Associated with Deep Endometriosis

Overview
Date 2023 Apr 3
PMID 37010333
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is no agreed consensus on the optimal surgical treatment for pain associated with endometriosis.

Objectives: To compare improvement in symptoms and quality-of-life in patients undergoing excisional endometriosis surgery (EES) versus EES with hysterectomy and bilateral salpingo-oophorectomy (EES-HBSO).

Methods: This study evaluated patients undergoing EES and EES-HBSO at a single endometriosis centre between 2009 and 2019. Data was obtained from the British Society for Gynaecological Endoscopy database. Adenomyosis was assessed by blinded re-analysis of imaging and/or histology data.

Main Outcome Measures: Pain scores (numeric rating scale 0-10) and quality-of-life scores (EQ-VAS) before and after EES and EES-HBSO.

Results: We included 120 patients undergoing EES and 100 patients undergoing EES-HBSO. After controlling for baseline characteristics and the presence of adenomyosis, there was greater post-op improvement in non-cyclical pelvic pain amongst patients undergoing EES-HBSO compared to EES alone.The baseline pain scores had improved in the EES-HBSO cohort by 2.106/10 at 6 months (95%CI 0.469-3.742, p=0.012), 2.642/10 at 12 months (95%CI 0.871-4.413, p=0.004), and 2.548/10 at 24 months (95%CI 0.681-4.414, p=0.008), when compared to the EES group. Greater improvement amongst EES-HBSO patients was also seen for dyspareunia, non-cyclical dyschaezia and bladder pain. Patients undergoing EES-HBSO had greater improvement in EQ-VAS, although this was no longer statistically significant after controlling for adenomyosis.

Conclusion: EES-HBSO appears to provide greater benefit than EES alone for symptoms including non-cyclical pelvic pain as well as for quality-of-life. Further research is required to determine which patients benefit the most from EES-HBSO, and whether removal of the ovaries, uterus or both is the key to this additional benefit in symptom control.

References
1.
Stewart K, Tessier K, Lebovic D . Comparing Characteristics of and Postoperative Morbidity after Hysterectomy for Endometriosis versus other Benign Indications: A NSQIP Study. J Minim Invasive Gynecol. 2022; 29(7):884-890.e2. PMC: 10084482. DOI: 10.1016/j.jmig.2022.04.009. View

2.
Sullivan M, Adams H, Tripp D, Stanish W . Stage of chronicity and treatment response in patients with musculoskeletal injuries and concurrent symptoms of depression. Pain. 2007; 135(1-2):151-9. DOI: 10.1016/j.pain.2007.05.021. View

3.
Surrey E, Soliman A, Yang H, Du E, Su B . Treatment Patterns, Complications, and Health Care Utilization Among Endometriosis Patients Undergoing a Laparoscopy or a Hysterectomy: A Retrospective Claims Analysis. Adv Ther. 2017; 34(11):2436-2451. PMC: 5702365. DOI: 10.1007/s12325-017-0619-3. View

4.
Bougie O, McClintock C, Pudwell J, Brogly S, Velez M . Short-term outcomes of endometriosis surgery in Ontario: A population-based cohort study. Acta Obstet Gynecol Scand. 2020; 100(6):1140-1147. DOI: 10.1111/aogs.14071. View

5.
Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J . Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017; 1:CD004143. PMC: 6465148. DOI: 10.1002/14651858.CD004143.pub5. View